SCHEMBL17422752

SCHEMBL17422752

COC(=O)c1cc2ccccc2cc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
NPSR1 Q6W5P4 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ATM Q13315 1/20 0.42
HSP90AA1 P07900 1/20 0.42
PAX8 Q06710 1/20 0.42
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
PLA2G2A P14555 1/20 0.40
POLB P06746 2/20 0.40
AHR P35869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952202 0.89 KDM4E (0.45) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL8106855 0.82 KMT2A (0.52) KDM4EALDH1A1SLC6A4SLC6A3MAPT
SCHEMBL2324864 0.78 MAPT (0.44) KDM4EALDH1A1HPGDNPSR1NPC1
SCHEMBL620668 0.78 ALDH1A1 (0.71) KDM4EALDH1A1HPGDNPSR1SLC6A2
SCHEMBL21912867 0.77 CA12 (0.37) KDM4EALDH1A1HPGDSLC6A3RAB9A
SCHEMBL7627705 0.77 MAPT (0.44) KDM4EALDH1A1HPGDNPSR1RAB9A
SCHEMBL5058599 0.77 GAA (0.49) KDM4EALDH1A1HPGDRAB9AMAPT
SCHEMBL12553766 0.77 ABL1 (0.51) KDM4EALDH1A1HPGDSLC6A4SLC6A3
SCHEMBL16300514 0.77 ELANE (0.51) KDM4EALDH1A1HPGDNPSR1SLC6A2
SCHEMBL6120246 0.76 SOS1 (0.35) KDM4EALDH1A1HPGDSLC6A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2017-08-03 US disclosed
WO-2016004513-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2016-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS PDK1, PDK3, PDK2 KDM4E 1649/4885ALDH1A1 2424/4885HPGD 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.